Your browser doesn't support javascript.
loading
Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial.
Karthaus, M; Kretzschmar, A; Kröning, H; Biakhov, M; Irwin, D; Marschner, N; Slabber, C; Fountzilas, G; Garin, A; Abecasis, N G F; Baronius, W; Steger, G G; Südhoff, T; Giorgetti, C; Reichardt, P.
Affiliation
  • Karthaus M; Evang. Johannes-Krankenhaus, Medizinische Klinik, Bielefeld, Germany. Meinolf.Karthaus@evkb.de
Ann Oncol ; 17(2): 289-96, 2006 Feb.
Article in En | MEDLINE | ID: mdl-16317012
Search on Google
Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Thromboembolism / Catheterization, Central Venous / Catheters, Indwelling / Dalteparin / Anticoagulants Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Year: 2006 Document type: Article
Search on Google
Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Thromboembolism / Catheterization, Central Venous / Catheters, Indwelling / Dalteparin / Anticoagulants Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Year: 2006 Document type: Article